HOOKIPA (HOOK) fell 20% Friday, the day after the company released updated results from a Phase 1/2 study of its drug HB-200
https://seekingalpha.com/news/4110331-hookipa-stock-falls-in-wake-of-phase-12-study-results
HOOKIPA (HOOK) fell 20% Friday, the day after the company released updated results from a Phase 1/2 study of its drug HB-200
https://seekingalpha.com/news/4110331-hookipa-stock-falls-in-wake-of-phase-12-study-results
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.